|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.35 USD | +4.69% |
|
-.--% | -.--% |
Dar Al-Shifa Pharmaceuticals Company reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was USD 30.71 million compared to USD 22.98 million a year ago. Net income was USD 4.87 million compared to USD 2.6 million a year ago.
Basic earnings per share from continuing operations was USD 0.566 compared to USD 0.303 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 30.15M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
DAR AL-SHIFA PHARMACEUTICALS COMPANY 
